MitoCarn™ Heart

Your heart contains more mitochondria than any other organ in your body with about 5,000 mitochondria per cell. MitoCarn™ Heart provides one of the compounds your heart requires to produce a healthy energy supply and help maintain healthy mitochondrial function.*

MitoCarn™ Heart can help support healthy functioning of mitochondria of heart cells

Levels of L-Carnitine in myocardial cells decline with age. MitoCarn™ Heart helps maintain healthy levels of L-Carnitine, which in turn may help maintain healthy ATP energy production within the heart muscle, slowing the decline in energy levels associated with aging. MitoCarn™ Heart also helps reduce oxidative stress through antioxidant activity, which helps maintain mitochondrial health.*

MitoCarn formulations for heart health

MitoCarn™ Heart Specifics

Formulators developing heart health products typically use the unique MitoCarn™ Heart formulation. This compound supports improved:

  • ATP energy production*
  • Healthy blood flow to the heart*
  • Heart muscle function*
  • Antioxidant activity*
  • Removal of metabolism byproducts from mitochondria*

MitoCarn™ Heart is a 100% active L-Carnitine compound designed to be used in liquid, gelcap, capsule, tablet, gummy, and powder formulations requiring a high concentration of active L-Carnitine. It is guaranteed to be:

  • BSE-TSE risk-free (according to the European Guidelines (EMEA-410/01 rev. 3.))
  • Melamine-free
  • Pesticide-free
  • Allergen-free (according to European Directive 2000/13/EC, Regulation (EU) No. 1169/2011 and latest amendments)
  • Non-GMO
  • Not sterilized or processed with radiation
  • Not engineered with nanomaterials


Supported Delivery Systems for Formulators

MitoCarn™ Heart is a 100% active, high concentration of L-Carnitine designed to be used in: 

Clinical studies show MitoCarn™ Heart may help strengthen normal cardiovascular function

Clinical studies on the effects of MitoCarn™ Heart on heart muscle may show improved resilience. By helping the myocardium create energy and restore depleted cells, MitoCarn™ Heart helps the hardest working muscle in your body function properly.*

L-Carnitine performs an essential role in myocardial energy production at the mitochondrial level. It transports long-chain fatty acids across the inner mitochondrial membrane for beta oxidation and also removes accumulated byproducts of metabolism (toxic intermediates) from the mitochondria. 

Myocardial L-Carnitine levels drop during ischemia, acute myocardial infarction, and cardiac failure. Numerous studies have been conducted over the past 40 years to test whether supplementation of L-Carnitine can help the heart remain resilient in the face of physiological strain. MitoCarn™ Heart helps support healthy blood pressure and the body’s natural inflammatory response processes.*

Myocardial Clinical Studies with MitoCarn™ Heart

Bigalli, D.P., Lamanna, F., Boem, A., Davini, P., Controlled Study on L-Carnitine Therapeutic Efficacy in Post-Infarction. Drugs Exptl. Clin. Res. XVIII(8) 355-365. 1992. Summary: This 12-month study on 160 patients following myocardial infarction showed that L-Carnitine represents an effective treatment in post-infarction ischaemic cardiopathy. Download PDF »

Casciani, C. U. et al., Beneficial Effects of L-Carnitine in Post-dialysis Syndrome. Current Therapeutic Research, Vol. 32, No. 1. July, 1982. Summary: Dialysis patients have low muscle concentrations of L-Carnitine. This study’s findings suggest that providing muscle cells with free L-Carnitine supported the health of patients undergoing dialysis. Download PDF »

Corbucci, G.C., Lochi, F. L-Carnitine in Cardiogenic Shock Therapy: Pharmacodynamic Aspects and Clinical Data. Int. J. Clin. Pharm. Res. XIII, 2, pp. 87-91. 1993. Summary: L-Carnitine is heavily involved in the production and utilization of ATP energy in myocardial cells. L-Carnitine depletion in these cells correlates with higher rates of Cardiogenic Shock. Download PDF »

Iliceto, S., et al. Effects of L-Carnitine Administration on Left Ventricular Remodeling After Acute Anterior Myocardial Infarction: The L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. JACC Vol. 26, No. 2, pp. 380-387. 1995. Summary: L-Carnitine treatment in the first year after acute myocardial infarction attenuated left ventricular dilation compared to a placebo. Download PDF »

Rizzon, P., et al. High Doses of L-Carnitine in Acute Myocardial Infarction: Metabolic and Antiarrhythmic Effects. European Heart Journal. Vol 10., pp. 502-508. 1989. Summary: Exogenous supplementation of L-Carnitine effectively increased free L-Carnitine in the blood and in the urine. Download PDF »

Tarantini, G., et al., Metabolic Treatment with L-Carnitine in Acute Anterior ST Segment Elevation Myocardial Infarction. Cardiology, Vol. 106, pp. 215-223. 2006. DOI: 10.1159/000093131. Summary: L-Carnitine therapy led to a reduction in early mortality in patients who had previously experienced anterior acute myocardial infarction (AMI). Download PDF »

Winter, S.C., et al. L-Carnitine for Treatment of Cardiomyopathies. Cardiologia. (Suppl 2), pp. 685-686. 1998. Summary: In pediatric patients with compromised myocardial function, L-Carnitine supplementation helped restore metabolism to a more normal state with improvements in strength, muscle tone, and myocardial contractility. Download PDF »



More Solutions

Learn more ways that MitoCarn offers cellular support.